Lawmakers Urge VA to Draft Plan for MDMA-Assisted Therapy Ahead of Potential FDA Approval. A group of bipartisan congressional representatives is calling on the U.S. Department of Veterans Affairs (VA) to prepare a plan for providing MDMA-assisted therapy to veterans. This call comes in anticipation of the Food and Drug Administration (FDA) approving the therapy as a treatment for post-traumatic stress disorder (PTSD). The lawmakers believe that without sufficient preparation, veterans may end up sourcing treatments from providers lacking requisite expertise and military context understanding, potentially posing significant costs to VA. The FDA has granted priority status to the review of MDMA-assisted therapy, targeting a determination date of August 11. House representatives, including both Democrats and Republicans, want official plans detailing care models and timelines for MDMA therapy administration and staff training. They have asked the VA to provide this strategic plan by July 1.